8-K - Esperion Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Management Change

Regulation Fd

Exhibits Only

Disclosure

Mandatory

Variant

8-K

Items Reported

5.02

. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensation Arrangements of Certain Officers. On July 1,

Management Change

$700.0MMr. Thompson in connection with his appointment to the Board which is in substantially the same form as that entered into with the existing directors of the Company

7.01

, including Exhibit 99.1 attached hereto, is intended to be furnished and shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act

Regulation Fd

9.01

. Financial Statements and Exhibits. Exhibit No. Description 99.1 Press Release dated July 1, 2025. 104 The cover page from this Current Report on Form 8-K, for

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1